Generics - Pharmaceutical, Financial


Current filters:


Popular Filters

1 to 25 of 93 results

Philippine government increasing financial support for health care spending


The size of the Philippine pharmaceutical market, now worth around $3.2 billion, is expected to expand…

Asia-PacificFinancialGenericsMarkets & MarketingPharmaceutical

Generic drugs slow pharma spending growth in Canada

Generic drugs slow pharma spending growth in Canada


Last year, C$29.3 billion ($26.47 billion) was spent on prescription drugs in Canada, but the annual…

CanadaFinancialGenericsMarkets & MarketingNorth AmericaPharmaceutical

Setting the record straight: Australia’s PBS expenditure is in decline


Comments made this week by Australia’s federal Health Minister, Peter Dutton MP, about expenditure…


Dr Reddy’s sees generics soar due to limited competition

Dr Reddy’s sees generics soar due to limited competition


India’s second-largest drugmaker Dr Reddy's Laboratories has reported strong third quarter sales of…

Dr Reddy's LaboratoriesFinancialGenericsIndiaPharmaceutical

Teva’s full year results steady led by Copaxone sales up 8%

Teva’s full year results steady led by Copaxone sales up 8%


Israel-based Teva Pharmaceutical Industries has released its full year results for 2014 showing that…

CopaxoneEastern EuropeFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Spain continues reduction of pharma spending and starts adopting value based pricing


The Spanish Ministry of Health last week announced pharmaceutical spending data, which showed a new drop…


US national health spending growth remains low for 4th consecutive year


Overall national health expenditures in the USA grew at an annual rate of 3.7% in 2012, marking the fourth…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalUSA

Low level of “potentially problematic” patent settlements in EU pharma sector

Low level of “potentially problematic” patent settlements in EU pharma sector


The European Commission's report on patent settlement agreements, also referred to as “pay-for-delay”…


Promising outcome of EU platform on access to medicines in Africa


The Platform on Access to Medicines in Developing Countries with a Focus on Africa took a step forward…

EuropeFinancialGenericsHealthcarePharmaceuticalRest of the World

Increase of Japan's medical expenditure slowed to 1.7% in 2012


The Japanese Ministry of Health, Labor and Welfare (MHLW) reported approximate medical expenditure (AME)…


Advance Pharmaceutical to invest $25 million in building plant in Russia


USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility…

Advance PharmaceuticalEuropeFinancialGenericsPharmaceuticalProduction

Lundbeck files appeal over EC pay-for-delay fine


Denmark-based CNS specialist drugmaker Lundbeck (LUND: CO) has filed its appeal against the European…


Pharmstandard commits $30 million to Argos Therapeutics; post 1st-half results


Russia's largest drugmaker Pharmstandard (PHST: RU) that its subsidiary Pharmstandard International.(Luxembourg)…

AGS-003Argos TherapeuticsFinancialGenericsOncologyPharmaceuticalPharmstandardResearch

Stada Arz buys UK OTC manufacturer


German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

Hikma first half EPS beats expectations; raises guidance


Jordan-headquartered drugmaker Hikma Pharmaceuticals (HIK: LSE) this morning (August 21) reported financial…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions


In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

Teva Pharma sees slowdown in generic revenues


Israel-based Teva Pharmaceutical Industries (NYSE: TEVA), the world largest generics firm but with a…

CopaxoneFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Novartis 2nd-quarter in line with analysts' forecasts


Novartis 2nd-quarter in line with analysts' forecasts


Statin drugs save health care systems money as well as saving lives, UK study shows


Statins not only help save lives but are great value for money too, even in lower risk patients, according…


US pharma patent settlements netted $25.5 billion in savings for health system; report


Generic pharmaceuticals launched prior to patent expiration due to a patent settlement - also called…

FinancialGenericsNorth AmericaPatentsPharmaceutical

$200+ billion annual opportunity in USA from using medicines more responsibly, IMS finds


Avoidable costs of more than $200 billion are incurred each year in the US health care system as a result…

Antibiotics and Infectious diseasesDiabetesFinancialGenericsHealthcareNorth AmericaPharmaceutical

1 to 25 of 93 results

Back to top